“…Furthermore, this understanding facilitates the identification of new pharmacological targets and promising therapeutic approaches, such as small molecules, growth factors, or non-coding RNAs. For instance, antidepressants that enhance neurotrophic factor production or anxiolytics that suppress neuroinflammation can be prescribed, combining the effects of 10.3389/fnmol.2024.1361764 Frontiers in Molecular Neuroscience 14 frontiersin.org symptomatic and pathogenetic therapies (Nibuya et al, 1995;Zheng et al, 2023). However, elucidating the contribution and functional significance of specific genes and their variants in neural tissue development warrants further investigation using cellular or animal models, which is now becoming increasingly accessible due to the possibilities of modern genetic and cellular technologies (Białoń and Wąsik, 2022;Dougnon and Matsui, 2022;Karagyaur et al, 2022).…”